Integrative analysis of fecal metabolomics and metagenomics for Parkinson’s disease
Objective: The objectives of the current study were to explore how the fecal metabolomics changed, and how they interacted with the alteration of microbiota in…Opicapone’s Effects on Progression Scales in Relation to the 9-Symptom Wearing-off Questionnaire: the OPTIPARK Study
Objective: This study aims to evaluate changes in Parkinson’s disease (PD) progression scales in patients with PD and motor fluctuations (MF) treated with once-daily opicapone…Long-term dementia prevalence in Parkinson disease: Glass half-full?
Objective: To determine long-term, cumulative dementia prevalence rates in Parkinson disease (PD) using data from two large, ongoing, prospective observational studies. Background: Dementia is reported to occur in…Brain MRI volumetry analysis for patients with Parkinson’s disease suffering from REM sleep behavior disorder: a pilot study
Objective: To detect patients with Parkinson's disease that have REM sleep behavior disorder (RBD) and perform brain MRI volumetry analysis. Background: Parkinson’s disease is classically…Frequency of Parkinson disease following COVID-19 infection: a two-year retrospective cohort study
Objective: We aimed to utilize a large healthcare research network to determine the risk of developing Parkinson disease following COVID-19 infection compared individuals without COVID-19…Impact of dopamine replacement therapy on shame in Parkinson’s disease patients
Objective: This study aims to investigate the effect of dopaminergic replacement therapy (DRT) on shame using emotional dynamic rating scales during ON and OFF-DRT states.…Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson’s disease.The AMBITIOUS Study Protocol
Objective: To determine in Parkinson’s disease (PD) patients carrying GBA mutation the role of Ambroxol (ABX) on the progression of cognitive performance (primary aim), motor…Feasibility and acceptability of implementing dignity therapy as a supportive intervention for people with movement disorders.
Objective: To determine the feasibility and acceptability of implementing Dignity Therapy (DT) in a neuropalliative clinic, and to determine preliminary efficacy. Background: Awareness of the…Clinical and radiological characteristics of elder patients of Parkinson’s disease with the onset age of more than 80 years old
Objective: We investigated clinical and radiological findings of elder PD patients with the onset of more than 80 years old using clinical examinations, brain CT/MRI…Clinical implication of small vessel disease burden on deep brain stimulation outcome in Parkinson’s disease
Objective: We aimed to investigate the correlation between the small vessel disease (SVD) burden and the 1-year outcome after the globus pallidus interna (GPi) deep…
- « Previous Page
- 1
- …
- 195
- 196
- 197
- 198
- 199
- …
- 436
- Next Page »